These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10999199)

  • 1. Imaging monoamine oxidase B receptor mapping.
    Reutens DC
    Adv Neurol; 2000; 83():173-6. PubMed ID: 10999199
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoamine oxidase B single-photon emission tomography with [123I]Ro 43-0463: imaging in volunteers and patients with temporal lobe epilepsy.
    Buck A; Frey LD; Bläuenstein P; Krämer G; Siegel A; Weber B; Schubiger PA; Wieser HG
    Eur J Nucl Med; 1998 May; 25(5):464-70. PubMed ID: 9575241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pro-psychotic metabotropic glutamate receptor compounds fenobam and AZD9272 share binding sites with monoamine oxidase-B inhibitors in humans.
    Varnäs K; Cselényi Z; Arakawa R; Nag S; Stepanov V; Moein MM; Johnström P; Kingston L; Elmore CS; Halldin C; Farde L
    Neuropharmacology; 2020 Jan; 162():107809. PubMed ID: 31589885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The active centers of monoamine oxidase types "A" and "B": binding with (14C)-clorgyline and (14C)-deprenyl.
    Youdim MB
    J Neural Transm; 1978; 43(3-4):199-208. PubMed ID: 745012
    [No Abstract]   [Full Text] [Related]  

  • 5. Positron emission tomography with [11C]deuterium-deprenyl in temporal lobe epilepsy.
    Kumlien E; Bergström M; Lilja A; Andersson J; Szekeres V; Westerberg CE; Westerberg G; Antoni G; Långström B
    Epilepsia; 1995 Jul; 36(7):712-21. PubMed ID: 7555990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of cerebral monoamine oxidase B activity using L-[11C]deprenyl and dynamic positron emission tomography.
    Lammertsma AA; Bench CJ; Price GW; Cremer JE; Luthra SK; Turton D; Wood ND; Frackowiak RS
    J Cereb Blood Flow Metab; 1991 Jul; 11(4):545-56. PubMed ID: 1904879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET: opiate neuroreceptor mapping.
    Koepp MJ; Duncan JS
    Adv Neurol; 2000; 83():145-56. PubMed ID: 10999196
    [No Abstract]   [Full Text] [Related]  

  • 8. Temporal lobe epilepsy visualized with PET with 11C-L-deuterium-deprenyl--analysis of kinetic data.
    Bergström M; Kumlien E; Lilja A; Tyrefors N; Westerberg G; Långström B
    Acta Neurol Scand; 1998 Oct; 98(4):224-31. PubMed ID: 9808270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dynamic observation by PET in epilepsy].
    Shimizu H; Ishijima B; Iio M
    No To Shinkei; 1990 May; 42(5):463-74. PubMed ID: 2206634
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of the binding site for d-deprenyl in human inflamed synovial membrane.
    Lesniak A; Aarnio M; Diwakarla S; Norberg T; Nyberg F; Gordh T
    Life Sci; 2018 Feb; 194():26-33. PubMed ID: 29221756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET: cholinergic neuroreceptor mapping.
    Pennell PB
    Adv Neurol; 2000; 83():157-63. PubMed ID: 10999197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproducibility of repeated measures of deuterium substituted [11C]L-deprenyl ([11C]L-deprenyl-D2) binding in the human brain.
    Logan J; Fowler JS; Volkow ND; Wang GJ; MacGregor RR; Shea C
    Nucl Med Biol; 2000 Jan; 27(1):43-9. PubMed ID: 10755644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition.
    Fowler JS; Volkow ND; Wang GJ; Pappas N; Logan J; MacGregor R; Alexoff D; Wolf AP; Warner D; Cilento R; Zezulkova I
    J Addict Dis; 1998; 17(1):23-34. PubMed ID: 9549600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of monoamine oxidase type A, but not type B, is an effective means of inducing anticonvulsant activity in the kindling model of epilepsy.
    Löscher W; Lehmann H; Teschendorf HJ; Traut M; Gross G
    J Pharmacol Exp Ther; 1999 Mar; 288(3):984-92. PubMed ID: 10027835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo properties of N-(2-aminoethyl)-5-halogeno-2-pyridinecarboxamide 18F- and 123I-labelled reversible inhibitors of monoamine oxidase B.
    Bläuenstein P; Rémy N; Buck A; Ametamey S; Häberli M; Schubiger PA
    Nucl Med Biol; 1998 Jan; 25(1):47-52. PubMed ID: 9466361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.
    Henchcliffe C; Schumacher HC; Burgut FT
    Expert Rev Neurother; 2005 Nov; 5(6):811-21. PubMed ID: 16274338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent and selective MAO-B inhibitory activity: amino- versus nitro-3-arylcoumarin derivatives.
    Matos MJ; Rodríguez-Enríquez F; Vilar S; Santana L; Uriarte E; Hripcsak G; Estrada M; Rodríguez-Franco MI; Viña D
    Bioorg Med Chem Lett; 2015 Feb; 25(3):642-8. PubMed ID: 25532905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Brain monoamine oxidase and its inhibitors in gerontology (review of the literature)].
    Burchinbskiĭ SG; Kuznetsova SM
    Vopr Med Khim; 1988; 34(4):2-9. PubMed ID: 3057739
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Monoamine oxidase active site; the binding to and titration of monoamine oxidase with (14C)-selective inhibitors.
    Youdim MB
    Br J Pharmacol; 1976 Mar; 56(3):375P. PubMed ID: 1260203
    [No Abstract]   [Full Text] [Related]  

  • 20. Single photon emission computed tomography.
    Mullan BP; O'Connor MK; Hung JC
    Neuroimaging Clin N Am; 1995 Nov; 5(4):647-73. PubMed ID: 8564288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.